Abiopharma

Clinical trial NCT06468228 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 1400 participants

Clinical trial NCT07335601 updates: 1. completion date: 2027-12-01 → 2029-03-01 2. primary completion date: 2027-07-01 → 2028-08-01 3. enrollment: not set → 120 participants

Clinical trial NCT06431893 updates: 1. completion date: 2027-01-01 → 2030-08-01 2. primary completion date: 2027-01-01 → 2030-08-01 3. enrollment: not set → 100 participants

Register of shareholders, changes and share capital status - expiration of warrants

Cemex, Port Tampa Bay and Mayor Castor Complete $36M Terminal Expansion to Support Regional Growth

Blue Ops Ramps into Full-Rate Production of U.S.-Built Variant 7, Advancing Red Cat’s Autonomy Stack Across Air, Land and Sea

Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026

U.S. Firms Transform Digital Engineering with AI

Keysight Tackles Semiconductor Talent Gap with Executable RF Design Whiteboard

Gloo Announces 2026 AI Hackathon Focused on “Building Together: Humans, Agents and the Future of Flourishing”